Clinical Trials

Showing trials with last updates posted in 2021.

NCT04989322 | UNKNOWN | PHASE2
46 participants

Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2021-12-08
Start Date:
2021-10-05
Completion:
2024-08-31
Conditions
  • Nsclc
  • EGFR Activating Mutation
  • EGF-R Positive Non-Small Cell Lung Cancer
  • ALK Gene Rearrangement Positive
  • ROS1 Gene Rearrangement
  • ROS1 Positive NSCLC - Reactive Oxygen Species 1 Positive Non-Small Cell Lung Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page